Combined burden and functional impact tests for cancer driver discovery using DriverPower
- Resource Type
- Source
- Nature Communications
Nature Communications, Vol 11, Iss 1, Pp 1-12 (2020)
Shuai, S, Abascal, F, Amin, S B, Bader, G D, Bandopadhayay, P, Barenboim, J, Beroukhim, R, Bertl, J, Boroevich, K A, Brunak, S, Campbell, P J, Carlevaro-Fita, J, Chakravarty, D, Chan, C W Y, Chen, K, Choi, J K, Deu-Pons, J, Dhingra, P, Diamanti, K, Feuerbach, L, Fink, J L, Fonseca, N A, Frigola, J, Gambacorti-Passerini, C, Garsed, D W, Gerstein, M, Getz, G, Guo, Q, Gut, I G, Haan, D, Hamilton, M P, Haradhvala, N J, Harmanci, A O, Helmy, M, Herrmann, C, Hess, J M, Hobolth, A, Hodzic, E, Hong, C, Hornshøj, H, Isaev, K, Izarzugaza, J M G, Johnson, R, Johnson, T A, Juul, M, Juul, R I, Kahles, A, Pedersen, J S, Sidiropoulos, N, Weischenfeldt, J, PCAWG Drivers and Functional Interpretation Working Group & PCAWG Consortium 2020, ' Combined burden and functional impact tests for cancer driver discovery using DriverPower ', Nature Communications, vol. 11, no. 1, 734 . https://doi.org/10.1038/s41467-019-13929-1
Nature Communications, 11 (1)
Nature Communications, 11
Nature Communications, 11, 1
Nature communications, vol 11, iss 1
Shuai, Shimin; Gallinger, Steven; Stein, Lincoln (2020). Combined burden and functional impact tests for cancer driver discovery using DriverPower. Nature communications, 11(1), p. 734. Nature Publishing Group 10.1038/s41467-019-13929-1
Shuai, S, PCAWG Drivers and Functional Interpretation Working Group, Gallinger, S, Stein, L & PCAWG Consortium 2020, ' Combined burden and functional impact tests for cancer driver discovery using DriverPower ', Nature Communications, vol. 11, no. 1, 734 . https://doi.org/10.1038/s41467-019-13929-1
NATURE COMMUNICATIONS - Subject
0301 basic medicine Cancer genome sequencing Mutation rate Medizin General Physics and Astronomy VARIANTS Genome Receptors, G-Protein-Coupled 0302 clinical medicine Peptide Elongation Factor 1 PCAWG Drivers and Functional Interpretation Working Group Mutation Rate Neoplasms BINDING Receptors Medicine and Health Sciences HETEROGENEITY RECURRENT Càncer lcsh:Science 610 Medicine & health Cancer Multidisciplinary Women's cancers Radboud Institute for Molecular Life Sciences [Radboudumc 17] MEF2 Transcription Factors Genomics Women's cancers Radboud Institute for Health Sciences [Radboudumc 17] 030220 oncology & carcinogenesis F1 score Medical Genetics Medical genomics Algorithms Human EXPRESSION ACETYLATION SOMATIC MUTATION Science Computational biology Biology General Biochemistry, Genetics and Molecular Biology Article 03 medical and health sciences G-Protein-Coupled Germline mutation Genetics Humans Genomes MOF Medicinsk genetik Whole genome sequencing Whole Genome Sequencing Genome, Human Human Genome Biology and Life Sciences PCAWG Consortium General Chemistry Oncogenes 030104 developmental biology Good Health and Well Being Mutation CHROMATIN ORGANIZATION cancer genome sequencing, DriverPower, Software, MEF2 Transcription Factors, Neoplasms, Mutation Rate lcsh:Q PATHOGENICITY Software Coding (social sciences) - Language
- English
- ISSN
- 2041-1723